LinkedIn

 آمار

تعداد نشریات21
تعداد شماره‌ها1,283
تعداد مقالات11,732
تعداد مشاهده مقاله82,730,539
تعداد دریافت فایل اصل مقاله121,612,884
Nazari Taloki, Zahra. (1405). Topical Vinpocetine as a Potential Adjuvant Therapy for Chronic Anal Fissure: A Drug Repurposing Hypothesis. سامانه مدیریت نشریات علمی, (), -. doi: 10.30476/ijms.2026.109670.4502
Zahra Nazari Taloki. "Topical Vinpocetine as a Potential Adjuvant Therapy for Chronic Anal Fissure: A Drug Repurposing Hypothesis". سامانه مدیریت نشریات علمی, , , 1405, -. doi: 10.30476/ijms.2026.109670.4502
Nazari Taloki, Zahra. (1405). 'Topical Vinpocetine as a Potential Adjuvant Therapy for Chronic Anal Fissure: A Drug Repurposing Hypothesis', سامانه مدیریت نشریات علمی, (), pp. -. doi: 10.30476/ijms.2026.109670.4502
Nazari Taloki, Zahra. Topical Vinpocetine as a Potential Adjuvant Therapy for Chronic Anal Fissure: A Drug Repurposing Hypothesis. سامانه مدیریت نشریات علمی, 1405; (): -. doi: 10.30476/ijms.2026.109670.4502

Topical Vinpocetine as a Potential Adjuvant Therapy for Chronic Anal Fissure: A Drug Repurposing Hypothesis

Iranian Journal of Medical Sciences
مقالات آماده انتشار، اصلاح شده برای چاپ، انتشار آنلاین از تاریخ 22 تیر 1405    اصل مقاله (175.95 K)
نوع مقاله: Letter(s) to the Editor
شناسه دیجیتال (DOI): 10.30476/ijms.2026.109670.4502
نویسنده
Zahra Nazari Taloki* 1، 2
1Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran
2Department of Clinical Pharmacy, School of Pharmacy, Babol University of Medical Sciences, Babol, Iran
چکیده
Chronic anal fissure remains a distressing anorectal disorder that significantly reduces patients’ quality of life. 

تازه های تحقیق

Zahra Nazari Taloki (Google Scholar)

کلیدواژه‌ها
Vinpocetine؛ Anal canal؛ Vasodilation؛ Wound healing؛ Inflammation
مراجع
  1. Lyle V, Young CJ. Anal fissures: An update on treatment options. Aust J Gen Pract. 2024;53:33-5. doi: 10.31128/AJGP/05-23-6843. PubMed PMID: 38316476.
  2. Fagan C, Kolber MR, Lindblad AJ. Topical treatments for anal fissure. Can Fam Physician. 2023;69:33. doi: 10.46747/cfp.690133. PubMed PMID: 36693740; PubMed Central PMCID: PMC9873286.
  3. Chen X. Advancements in the application of botulinum toxin type a in the treatment of anorectal disorders. Toxi-con. 2025;260:108346. doi: 10.1016/j.toxicon.2025.108346. PubMed PMID: 40246206.
  4. Alshehri AA, Al-Kuraishy HM, Al-Gareeb AI, Jawad SF, Khawagi WY, Alexiou A, et al. The anti-inflammatory prop-erties of vinpocetine mediates its therapeutic potential in management of atherosclerosis. J Inflamm (Lond). 2024;21:19. doi: 10.1186/s12950-024-00394-x. PubMed PMID: 38858751; PubMed Central PMCID: PMC11165849.
  5. Barakat W, Anwar H, Mahmoud M. Sildenafil and vinpocetine promote wound healing in diabetic rats. J. Adv. Pharm. Res. 2021;5(1):211-21. doi: 10.21608/aprh.2020.34224.1113.
  6. Al-Kuraishy HM, Al-Gareeb AI, Naji MT, Al-Mamorry F. Role of vinpocetine in ischemic stroke and poststroke out-comes: A critical review. Brain Circ. 2020;6:1-10. doi: 10.4103/bc.bc_46_19. PubMed PMID: 32166194; PubMed Central PMCID: PMC7045535.
  7. Abu-Alghayth MH, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Bahaa MM, et al. Atheroprotective role of vinpocetine: an old drug with new indication. Inflammopharmacology. 2024;32:3669-78. doi: 10.1007/s10787-024-01529-5. PubMed PMID: 39141151; PubMed Central PMCID: PMC11550280.
  8. Salman HR, Alzubaidy AA, Abbas AH, Mohammad HA. Attenuated effects of topical vinpocetine in an imiquimod-induced mouse model of psoriasis. J Taibah Univ Med Sci. 2024;19:35-53. doi: 10.1016/j.jtumed.2023.09.002. PubMed PMID: 37868105; PubMed Central PMCID: PMC10585306.
  9. Lee YJ, Song JY, Lee SH, Lee Y, Hwang KT, Lee JY. Vinpocetine, a phosphodiesterase 1 inhibitor, mitigates atopic dermatitis-like skin inflammation. Korean J Physiol Pharmacol. 2024;28:303-12. doi: 10.4196/kjpp.2024.28.4.303. PubMed PMID: 38926838; PubMed Central PMCID: PMC11211756.
  10. Hard S, Shivakumar HN, Bafail DA, Moqbel Redhwan MA. Development of in vitro and in vivo evaluation of mucoad-hesive in-situ gel for intranasal delivery of vinpocetine. J Drug Target. 2025;33:528-45. doi: 10.1080/1061186X.2024.2433557. PubMed PMID: 39601452.
آمار
تعداد مشاهده مقاله: 11
تعداد دریافت فایل اصل مقاله: 5


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب